Practicalities
Step by step - the kit arrives, you sleep, you post it back, and what we do with the data.
LoveMyLife Sleep Medicine team
MRCGP-led, respiratory consultant-overseen
22 April 2026
6 min read

The WatchPAT One is the home sleep study we use as standard at LoveMyLife. It is a single-use, wrist-worn, disposable device with a finger sensor. You wear it for one night, post it back the next morning, and we get a full sleep study interpretation within a week. This article walks through exactly what to expect.
Four main signals:
- Peripheral arterial tone (PAT) via the finger probe - reflects sympathetic nervous system activation during arousals, apnoea events, and sleep-stage transitions - Oxygen saturation (SpO2) continuously overnight - Heart rate, variability, and pulse rhythm - Body position and motion
From these four signals, validated algorithms derive: apnoea-hypopnoea index (AHI), respiratory disturbance index (RDI), oxygen desaturation index (ODI), minimum SpO2, time below various SpO2 thresholds, sleep architecture estimates (light, deep, REM), sleep efficiency, and arousal burden.
In-lab polysomnography (PSG) is the gold standard: EEG, EOG, EMG, chin EMG, airflow, thoracic and abdominal effort belts, SpO2, body position, video. It is the full diagnostic test, and it is inconvenient (a night in a sleep lab, electrodes everywhere, a different bed).
The WatchPAT One is an alternative for obstructive sleep apnoea specifically. Its AHI has been validated against PSG across multiple studies and performs well across mild, moderate, and severe disease. It is not a full replacement for PSG in complex cases but is the appropriate tool for the majority of adults with suspected obstructive apnoea.
Where PSG still wins: suspected central sleep apnoea, suspected narcolepsy, complex parasomnias, some paediatric cases, CPAP titration in refractory cases. We refer to NHS or private labs for these.
We post the WatchPAT One to your home once you have booked the study. Delivery is usually next working day. The box contains the device, a finger probe, a wrist strap, a simple set of instructions, and a pre-paid return envelope.
You use it on a night that is representative of your typical sleep. Not a night after long travel, not an unusual environment, not a night following heavy alcohol (unless that is your typical pattern, in which case it is representative).
Set-up takes about 10 minutes. You pair the device with a free smartphone app that provides instructions. Put on the wrist band. Attach the finger probe. The app checks signal quality. Once everything is reading correctly, you go to sleep as normal.
You can get up overnight (toilet, water) without removing the device. You can sleep on your side, your back, or any position. The device is comfortable enough that most patients report normal sleep quality.
The device records automatically until the app ends the session, usually triggered by you sitting up and tapping a stop button. Remove it, seal it in the return envelope provided, and post first thing that morning or at the post office on the way to work.
The device gets back to us within 1 to 2 working days. Data is extracted, algorithmically analysed, and reviewed by our clinical team. We check for: adequate recording time (at least 4 hours), adequate signal quality, and any anomalies that might affect interpretation.
You get a written clinical report within 5 to 7 working days of us receiving the device. The report includes:
- Total recording time and analysable sleep time - AHI, RDI, ODI - Mean and minimum SpO2 - Time below 90 percent saturation (the cardiovascular risk marker) - Sleep architecture (light, deep, REM percentages) - Position-dependence of apnoea events - Clinical interpretation
We schedule a 30-minute video consultation (included in the assessment fee) to discuss the results. The conversation covers what the numbers mean for you specifically, what treatment options are appropriate, and what the next step looks like.
If the study is clearly negative, we explain why and discuss whether other sleep causes need to be investigated.
If the study is clearly positive, we agree a treatment plan. For moderate-to-severe apnoea, CPAP is usually the first option discussed. For mild positional apnoea, positional therapy or a mandibular device may be better first steps.
What if I do not sleep well that night? A single bad-sleep night is not usually disqualifying. If sleep time is very short (under 3 hours) we may repeat. If the study was representative of your typical night, even a short sleep gives useful information.
What if I drink alcohol? Try not to, if you do not normally. If your usual pattern includes moderate alcohol, keep it typical. Large-volume alcohol the night of the study distorts results and we may recommend repeating.
What if my partner snores and disrupts me? The WatchPAT One measures you, not your partner. Your partner's snoring does not affect your results (though if it disrupts your sleep architecture, that itself is a finding).
Can I sleep with my partner? Yes. No special arrangements needed.
What about children / pets in the room? No effect on the measurement. If you are disrupted by children or pets, note this and we interpret accordingly.
Will my wearable data match? Consumer wearables (Apple Watch, Oura, Whoop) are not directly comparable. They measure different signals with different algorithms. We do not rely on wearable data for diagnosis but we can incorporate it into longer-term monitoring.
What if I cannot sleep with the device? Rare but it happens. We can provide a second device if the first study is truly unanalysable. Occasionally patients need to move to a lab-based study.
AHI 2, ODI 1, minimum SpO2 92%, sleep architecture normal. No evidence of sleep apnoea. Complaint needs investigation in other directions (insomnia, circadian, mental health).
AHI 12, ODI 8, minimum SpO2 88%, predominantly supine. Mild positional apnoea. Treatment options: positional therapy as first-line, mandibular device as second, CPAP if symptoms are significant.
AHI 22, ODI 18, minimum SpO2 85%, REM-predominant. Moderate REM-related apnoea. CPAP indicated and likely to produce good symptomatic response.
AHI 45, ODI 38, minimum SpO2 79%, significant time below 90%. Severe apnoea. CPAP is first-line. Significant cardiovascular risk over time without treatment.
The WatchPAT One is included in both our Online Sleep Consultation (£395) and our In-Person Sleep Clinic (£595). No separate diagnostic charge. A repeat WatchPAT (to check treatment response) costs £195 standalone or is included in the Full Sleep Reset Programme (£895).
The WatchPAT One is a proper diagnostic tool, comfortable to use, and validated against the gold standard. For the majority of adults with suspected apnoea, it produces the right answer at home with minimum disruption. Where it is not the right tool (central apnoea, narcolepsy, complex parasomnias), we refer onward to appropriate services.
Clinically reviewed
Dr Seth Rankin · MBChB MRCGP - Founder and Medical Director, LoveMyLife
5 services
If this article has made you think our assessment might help, the next step is a short consultation with one of our sleep-medicine doctors.
Begin your consultation at this link. Online with a WatchPAT One home study, or in person at Westfield London.